Literature DB >> 23211363

Effects of dopamine D2/D3 receptor ligands on food-cocaine choice in socially housed male cynomolgus monkeys.

Paul W Czoty1, Michael A Nader.   

Abstract

Dopamine D2/D3 receptor partial agonists have been suggested as medications for cocaine dependence. The present experiments examined the effect of acute and repeated administration of drugs with varying intrinsic efficacy at D2/D3 receptors on the relative reinforcing strength of cocaine. Use of socially housed cynomolgus monkeys permitted the assessment of whether social status, known to alter D2/D3 receptor availability, influenced the behavioral effects of D2/D3 receptor compounds. The high-efficacy agonist R(-)-norpropylapomorphine [(-)-NPA], low-efficacy agonist aripiprazole (ARI), and antagonist eticlopride (ETIC) were administered acutely to monkeys self-administering cocaine under a food-cocaine choice procedure in which a cocaine self-administration dose-effect curve was determined daily. The effects of 5-day treatment with ARI and (-)-NPA were characterized under conditions in which monkeys did (ARI) or did not [ARI and (-)-NPA] self-administer cocaine during treatment. When administered acutely, ARI and ETIC increased the choice of low cocaine doses, and only (-)-NPA decreased the choice of higher cocaine doses and cocaine intake; effects were similar across social ranks. When administered repeatedly while self administration occurred only on days 1 and 5 of treatment, ARI, but not (-)-NPA, decreased cocaine choice in dominant monkeys, whereas (-)-NPA, but not ARI, did so in subordinates. When dominant monkeys self-administered cocaine on all five days of ARI treatment, however, these effects were not observed. The results indicate that the behavioral effects of D2/D3 receptor agonists can differ according to intrinsic efficacy and subject characteristics. Moreover, these results suggest that exposure to cocaine during treatment can counteract treatment-induced reductions in the reinforcing effects of cocaine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23211363      PMCID: PMC3558818          DOI: 10.1124/jpet.112.201012

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  54 in total

1.  Being partial to psychostimulant addiction therapy.

Authors:  Luigi Pulvirenti; George F Koob
Journal:  Trends Pharmacol Sci       Date:  2002-04       Impact factor: 14.819

2.  Pharmacotherapy and other treatments for cocaine abuse and dependence.

Authors:  Frank J Vocci; Ahmed Elkashef
Journal:  Curr Opin Psychiatry       Date:  2005-05       Impact factor: 4.741

3.  Assessment of the relative reinforcing strength of cocaine in socially housed monkeys using a choice procedure.

Authors:  Paul W Czoty; Ciara McCabe; Michael A Nader
Journal:  J Pharmacol Exp Ther       Date:  2004-08-30       Impact factor: 4.030

Review 4.  Aripiprazole.

Authors:  Jane K McGavin; Karen L Goa
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

5.  Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans.

Authors:  Joshua A Lile; William W Stoops; Paul E A Glaser; Lon R Hays; Craig R Rush
Journal:  J Psychopharmacol       Date:  2010-10-15       Impact factor: 4.153

6.  Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans.

Authors:  M Haney; A S Ward; R W Foltin; M W Fischman
Journal:  Psychopharmacology (Berl)       Date:  2001-06       Impact factor: 4.530

7.  The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripipirazole dose and maintenance period.

Authors:  Joshua A Lile; William W Stoops; Lon R Hays; Craig R Rush
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

8.  d-Amphetamine in squirrel monkeys of different social status: effects on social and agonistic behavior, locomotion, and stereotypies.

Authors:  K A Miczek; L H Gold
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats.

Authors:  Keri A Chiodo; Christopher M Läck; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2008-07-06       Impact factor: 4.530

10.  Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers.

Authors:  Suresh Mallikaarjun; Daniel E Salazar; Steven L Bramer
Journal:  J Clin Pharmacol       Date:  2004-02       Impact factor: 3.126

View more
  21 in total

1.  Effects of oral and intravenous administration of buspirone on food-cocaine choice in socially housed male cynomolgus monkeys.

Authors:  Paul W Czoty; Michael A Nader
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

Review 2.  William L. Woolverton: a case history in unraveling the behavioral pharmacology of stimulants.

Authors:  Michael A Nader; Robert L Balster; Jack E Henningfield
Journal:  Neuropharmacology       Date:  2014-05-20       Impact factor: 5.250

3.  Use of Preclinical Drug vs. Food Choice Procedures to Evaluate Candidate Medications for Cocaine Addiction.

Authors:  Matthew L Banks; Blake A Hutsell; Kathryn L Schwienteck; S Stevens Negus
Journal:  Curr Treat Options Psychiatry       Date:  2015-06

Review 4.  Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug.

Authors:  Frank N Perkins; Kevin B Freeman
Journal:  Pharmacol Biochem Behav       Date:  2017-06-27       Impact factor: 3.533

5.  Effects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys.

Authors:  Blake A Hutsell; Kejun Cheng; Kenner C Rice; Sidney Stevens Negus; Matthew L Banks
Journal:  Addict Biol       Date:  2015-01-08       Impact factor: 4.280

6.  Effects of Acute and Chronic Treatments with Dopamine D2 and D3 Receptor Ligands on Cocaine versus Food Choice in Rats.

Authors:  Morgane Thomsen; Andrew C Barrett; Paul Butler; S Stevens Negus; S Barak Caine
Journal:  J Pharmacol Exp Ther       Date:  2017-05-04       Impact factor: 4.030

7.  Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys.

Authors:  Paul W Czoty; H Donald Gage; Pradeep K Garg; Sudha Garg; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2013-09-29       Impact factor: 4.530

Review 8.  Environmental modulation of drug taking: Nonhuman primate models of cocaine abuse and PET neuroimaging.

Authors:  Michael A Nader; Matthew L Banks
Journal:  Neuropharmacology       Date:  2013-06-07       Impact factor: 5.250

9.  Performance on a strategy set shifting task in rats following adult or adolescent cocaine exposure.

Authors:  Kathleen M Kantak; Nicole Barlow; David H Tassin; Madeline F Brisotti; Chloe J Jordan
Journal:  Psychopharmacology (Berl)       Date:  2014-05-07       Impact factor: 4.530

10.  Effects of phendimetrazine treatment on cocaine vs food choice and extended-access cocaine consumption in rhesus monkeys.

Authors:  Matthew L Banks; Bruce E Blough; Timothy R Fennell; Rodney W Snyder; S Stevens Negus
Journal:  Neuropsychopharmacology       Date:  2013-07-30       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.